Advertisement

Author: Patsy Newitt

As operation costs skyrocket and reimbursements stagnate, ASCs are facing huge challenges to maintaining profitability. Here are five factors that can make or break ASCs in the coming years, according to seven ASC leaders. 

ASC surgery volume is projected to grow 25 percent in the next decade, according to an analysis from Sg2 Healthcare Intelligence, a Vizient company focused on market analytics and insights. 

The Federal Trade Commission has taken aim against a private-equity firms' healthcare deal in a move regulators say could spell trouble for other healthcare agreements the agency deems anticompetitive,  The Wall Street Journal reported recently.

Advertisement

Thirty percent of specialist physicians invested in a stock or company that turned out badly, according to Medscape's "Physician Wealth & Debt Report 2022."

Anesthesiologists in the East and South saw sizable drops in their median wages from 2021 to 2022, according to a June blog post from Tony Mira, Anesthesia Business Consultants' president and CEO.

Advertisement